275 related articles for article (PubMed ID: 25784973)
1. Sensitivity of (18)F-FDG PET in evaluation of solitary pulmonary nodules.
Yilmaz F; Tastekin G
Int J Clin Exp Med; 2015; 8(1):45-51. PubMed ID: 25784973
[TBL] [Abstract][Full Text] [Related]
2.
Taralli S; Scolozzi V; Foti M; Ricciardi S; Forcione AR; Cardillo G; Calcagni ML
Eur J Nucl Med Mol Imaging; 2019 Feb; 46(2):429-436. PubMed ID: 30535767
[TBL] [Abstract][Full Text] [Related]
3. Using neighborhood gray tone difference matrix texture features on dual time point PET/CT images to differentiate malignant from benign FDG-avid solitary pulmonary nodules.
Chen S; Harmon S; Perk T; Li X; Chen M; Li Y; Jeraj R
Cancer Imaging; 2019 Aug; 19(1):56. PubMed ID: 31420006
[TBL] [Abstract][Full Text] [Related]
4. Dynamic contrast-enhanced MRI versus
Feng F; Qiang F; Shen A; Shi D; Fu A; Li H; Zhang M; Xia G; Cao P
Chin J Cancer Res; 2018 Feb; 30(1):21-30. PubMed ID: 29545716
[TBL] [Abstract][Full Text] [Related]
5. Solitary pulmonary nodule evaluation in regions endemic for infectious diseases: Do regional variations impact the effectiveness of fluorodeoxyglucose positron emission tomography/computed tomography.
Purandare NC; Pramesh CS; Agarwal JP; Agrawal A; Shah S; Prabhash K; Karimundackal G; Jiwnani S; Tandon S; Rangarajan V
Indian J Cancer; 2017; 54(1):271-275. PubMed ID: 29199704
[TBL] [Abstract][Full Text] [Related]
6. (18)F-FDG-PET/CT in the assessment of pulmonary solitary nodules: comparison of different analysis methods and risk variables in the prediction of malignancy.
van Gómez López O; García Vicente AM; Honguero Martínez AF; Jiménez Londoño GA; Vega Caicedo CH; León Atance P; Soriano Castrejón ÁM
Transl Lung Cancer Res; 2015 Jun; 4(3):228-35. PubMed ID: 26207210
[TBL] [Abstract][Full Text] [Related]
7. Characterization of the solitary pulmonary nodule: 18F-FDG PET versus nodule-enhancement CT.
Christensen JA; Nathan MA; Mullan BP; Hartman TE; Swensen SJ; Lowe VJ
AJR Am J Roentgenol; 2006 Nov; 187(5):1361-7. PubMed ID: 17056930
[TBL] [Abstract][Full Text] [Related]
8. Performance of FDG-PET/CT in solitary pulmonary nodule based on pre-test likelihood of malignancy: results from the ITALIAN retrospective multicenter trial.
Evangelista L; Cuocolo A; Pace L; Mansi L; Del Vecchio S; Miletto P; Sanfilippo S; Pellegrino S; Guerra L; Pepe G; Peluso G; Salvatore M; Galicchio R; Zuffante M; Annunziata S; Farsad M; Chiaravalloti A; Spadafora M
Eur J Nucl Med Mol Imaging; 2018 Oct; 45(11):1898-1907. PubMed ID: 29736699
[TBL] [Abstract][Full Text] [Related]
9. Relation between nodule size and 18F-FDG-PET SUV for malignant and benign pulmonary nodules.
Khalaf M; Abdel-Nabi H; Baker J; Shao Y; Lamonica D; Gona J
J Hematol Oncol; 2008 Sep; 1():13. PubMed ID: 18808716
[TBL] [Abstract][Full Text] [Related]
10. Predictive value of dual-time
Pahk K; Chung JH; Kim S; Lee SH
Tumori; 2018 Jun; 104(3):207-212. PubMed ID: 29714664
[TBL] [Abstract][Full Text] [Related]
11. Application of CT Postprocessing Reconstruction Technique in Differential Diagnosis of Benign and Malignant Solitary Pulmonary Nodules and Analysis of Risk Factors.
Chen X; Xu B
Comput Math Methods Med; 2022; 2022():9739047. PubMed ID: 35983523
[TBL] [Abstract][Full Text] [Related]
12. The diagnostic role of dual-phase (18)F-FDG PET/CT in the characterization of solitary pulmonary nodules.
Demir Y; Polack BD; Karaman C; Ozdoğan O; Sürücü E; Ayhan S; Akkoçlu A; Ozdemir N
Nucl Med Commun; 2014 Mar; 35(3):260-7. PubMed ID: 24468852
[TBL] [Abstract][Full Text] [Related]
13. Tissue characterization of solitary pulmonary nodule: comparative study between helical dynamic CT and integrated PET/CT.
Yi CA; Lee KS; Kim BT; Choi JY; Kwon OJ; Kim H; Shim YM; Chung MJ
J Nucl Med; 2006 Mar; 47(3):443-50. PubMed ID: 16513614
[TBL] [Abstract][Full Text] [Related]
14. Limited diagnostic value of Dual-Time-Point (18)F-FDG PET/CT imaging for classifying solitary pulmonary nodules in granuloma-endemic regions both at visual and quantitative analyses.
Chen S; Li X; Chen M; Yin Y; Li N; Li Y
Eur J Radiol; 2016 Oct; 85(10):1744-1749. PubMed ID: 27666611
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic value of PET/CT in differentiating benign from malignant solitary pulmonary nodules.
Dalli A; Selimoglu Sen H; Coskunsel M; Komek H; Abakay O; Sergi C; Cetin Tanrikulu A
J BUON; 2013; 18(4):935-41. PubMed ID: 24344020
[TBL] [Abstract][Full Text] [Related]
16. Impact of solitary pulmonary nodule size on qualitative and quantitative assessment using 18F-fluorodeoxyglucose PET/CT: the SPUTNIK trial.
Weir-McCall JR; Harris S; Miles KA; Qureshi NR; Rintoul RC; Dizdarevic S; Pike L; Cheow HK; Gilbert FJ;
Eur J Nucl Med Mol Imaging; 2021 May; 48(5):1560-1569. PubMed ID: 33130961
[TBL] [Abstract][Full Text] [Related]
17. Amide proton transfer-weighted imaging to differentiate malignant from benign pulmonary lesions: Comparison with diffusion-weighted imaging and FDG-PET/CT.
Ohno Y; Kishida Y; Seki S; Yui M; Miyazaki M; Koyama H; Yoshikawa T
J Magn Reson Imaging; 2018 Apr; 47(4):1013-1021. PubMed ID: 28799280
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic efficacy of PET-FDG imaging in solitary pulmonary nodules. Potential role in evaluation and management.
Dewan NA; Gupta NC; Redepenning LS; Phalen JJ; Frick MP
Chest; 1993 Oct; 104(4):997-1002. PubMed ID: 8404239
[TBL] [Abstract][Full Text] [Related]
19. Solitary pulmonary nodules: morphological and metabolic characterisation by FDG-PET-MDCT.
Orlacchio A; Schillaci O; Antonelli L; D'Urso S; Sergiacomi G; Nicolì P; Simonetti G
Radiol Med; 2007 Mar; 112(2):157-73. PubMed ID: 17361379
[TBL] [Abstract][Full Text] [Related]
20. Is
Lee SH; Sung C; Lee HS; Yoon HY; Kim SJ; Oh JS; Song JW; Kim MY; Ryu JS
Ann Nucl Med; 2018 Aug; 32(7):492-498. PubMed ID: 29974372
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
